EDGAR Filing Documents for 0001410578-22-000418

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001410578-22-000418

Filing Date

2022-03-17

Accepted

2022-03-17 17:25:51

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	mrkr-20211231x10k.htm iXBRL	10-K	2302625
2	EX-21.1	mrkr-20211231xex21d1.htm	EX-21.1	1580
3	EX-23.1	mrkr-20211231xex23d1.htm	EX-23.1	2365
4	EX-31.1	mrkr-20211231xex31d1.htm	EX-31.1	11688
5	EX-31.2	mrkr-20211231xex31d2.htm	EX-31.2	11535
6	EX-32.1	mrkr-20211231xex32d1.htm	EX-32.1	6894
7	EX-32.2	mrkr-20211231xex32d2.htm	EX-32.2	5538
8	GRAPHIC	mrkr-20211231x10k001.jpg	GRAPHIC	10200
9	GRAPHIC	mrkr-20211231x10k002.jpg	GRAPHIC	30773
10	GRAPHIC	mrkr-20211231x10k003.jpg	GRAPHIC	32051
11	GRAPHIC	mrkr-20211231x10k004.jpg	GRAPHIC	12037
12	GRAPHIC	mrkr-20211231x10k005.jpg	GRAPHIC	13953
13	GRAPHIC	mrkr-20211231x10k006.jpg	GRAPHIC	30702
14	GRAPHIC	mrkr-20211231x10k007.jpg	GRAPHIC	22676
15	GRAPHIC	mrkr-20211231x10k008.jpg	GRAPHIC	20245
16	GRAPHIC	mrkr-20211231x10k009.jpg	GRAPHIC	13588
17	GRAPHIC	mrkr-20211231x10k010.jpg	GRAPHIC	48564
18	GRAPHIC	mrkr-20211231x10k011.jpg	GRAPHIC	65787
	Complete submission text file	0001410578-22-000418.txt		8057525

Data Files

Seq	Description	Document	Type	Size
19	EX-101.SCH	mrkr-20211231.xsd	EX-101.SCH	53714
20	EX-101.CAL	mrkr-20211231_cal.xml	EX-101.CAL	50783
21	EX-101.DEF	mrkr-20211231_def.xml	EX-101.DEF	148853
22	EX-101.LAB	mrkr-20211231_lab.xml	EX-101.LAB	368391
23	EX-101.PRE	mrkr-20211231_pre.xml	EX-101.PRE	312581
83	EXTRACTED XBRL INSTANCE DOCUMENT	mrkr-20211231x10k_htm.xml	XML	1037719

Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027

Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400

Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)